Afmed 20mg Tablet
Marketer
Medicamen Biotech Ltd
Salt Composition
Afatinib dimaleate (20mg)
Overview Afmed 20mg Tablet
Efgren 20mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include nausea, rash, dry skin, and diarrhea (which may require specific medical management and hydration). Regular blood tests may be recommended. Photosensitivity is possible; utilize sunscreen and protective clothing during sun exposure. Report any eye discomfort (pain, redness, dryness) to your physician. Prior to commencing treatment, disclose any respiratory, hepatic, or renal issues, or current use of anti-infectives. Significant drug interactions are possible; inform your healthcare provider of all medications you are currently taking. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for female patients undergoing treatment.
Uses of Afmed 20mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afmed 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Afmed 20mg Tablet should be taken on an empty stomach.
Common Side effects of Afmed 20mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afmed 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Afmed tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Afmed 20mg Tablet works:
Afmed 20mg tablets are an anticancer agent. Their mechanism of action involves targeted inhibition of enzyme receptors—EGFR, HER2, and HER4—crucial for cancer cell proliferation. This disruption of signaling pathways consequently reduces or halts tumor growth and metastasis.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Afmed 20mg Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Use of Afmed 20mg Tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Afmed 20mg Tablet while breastfeeding is likely inadvisable. Scant evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Afmed 20mg Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Afmed 20mg Tablets in individuals with kidney disease appears to present a low risk. Existing evidence indicates dose modification may be unnecessary, however, medical advice should be sought.
LiverSAFE IF PRESCRIBED
The use of Afmed 20mg Tablet in individuals with liver impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Afmed 20mg Tablet :
Omit any missed Afmed 20mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Afmed 20mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Kinase inhibitors targeting tyrosine |

